Guardian Pharmacy Services, Inc. (GRDN)

Price$37.34

Favorite Metrics

Price vs S&P 500 (26W)51.61%

Price vs S&P 500 (4W)-4.10%

Market Capitalization$2.38B

P/E Ratio (Annual)48.30x

All Metrics

P/CF (Annual)23.71x

Book Value / Share (Quarterly)$3.25

P/TBV (Annual)10.17x

Revenue Growth (3Y)16.81%

Cash Flow / Share (Quarterly)$1.27

Price vs S&P 500 (YTD)20.62%

Gross Margin (TTM)20.21%

Net Profit Margin (TTM)3.40%

EPS (TTM)$0.76

10-Day Avg Trading Volume0.46M

EPS Excl Extra (TTM)$0.76

Revenue Growth (5Y)14.50%

EPS (Annual)$0.78

ROI (Annual)23.07%

Gross Margin (Annual)20.21%

Net Profit Margin (5Y Avg)0.91%

Cash / Share (Quarterly)$1.04

P/E Basic Excl Extra (TTM)48.30x

Revenue Growth QoQ (YoY)17.44%

EPS Growth (5Y)19.34%

P/E Normalized (Annual)48.30x

ROA (Last FY)11.93%

Revenue Growth TTM (YoY)17.93%

EBITD / Share (TTM)$1.51

ROE (5Y Avg)39.71%

Operating Margin (TTM)5.02%

Cash Flow / Share (Annual)$1.27

P/B Ratio11.55x

P/B Ratio (Quarterly)9.26x

Net Income / Employee (Annual)$0

EV / Revenue (TTM)1.60x

Net Interest Coverage (TTM)111.41x

ROA (TTM)13.19%

EPS Growth QoQ (YoY)68.96%

EV / EBITDA (TTM)23.97x

EPS Incl Extra (Annual)$0.78

Current Ratio (Annual)1.38x

Quick Ratio (Quarterly)1.11x

3-Month Avg Trading Volume0.37M

52-Week Price Return59.61%

EV / Free Cash Flow (Annual)28.64x

P/E Incl Extra (TTM)48.30x

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$2.96

P/S Ratio (Annual)1.64x

Asset Turnover (Annual)3.51x

52-Week High$41.36

Operating Margin (5Y Avg)2.67%

EPS Excl Extra (Annual)$0.78

CapEx CAGR (5Y)18.57%

26-Week Price Return60.36%

Quick Ratio (Annual)1.11x

13-Week Price Return24.59%

Total Debt / Equity (Annual)0.04x

Current Ratio (Quarterly)1.38x

Enterprise Value$2,311.664

Revenue / Share Growth (5Y)14.07%

Asset Turnover (TTM)3.88x

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)27.55x

Pretax Margin (Annual)5.07%

Cash / Share (Annual)$1.04

3-Month Return Std Dev47.54%

Gross Margin (5Y Avg)20.16%

Net Income / Employee (TTM)$0

EBITDA CAGR (5Y)14.36%

ROE (Last FY)23.92%

Net Interest Coverage (Annual)111.41x

EPS Basic Excl Extra (Annual)$0.78

P/FCF (TTM)29.45x

Receivables Turnover (TTM)14.58x

EV / Free Cash Flow (TTM)28.64x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$0.76

Receivables Turnover (Annual)14.58x

ROI (TTM)27.53%

P/S Ratio (TTM)1.64x

Pretax Margin (5Y Avg)2.46%

Revenue / Share (Annual)$22.89

Tangible BV / Share (Annual)$2.96

Forward P/E30.51x

Free OCF CAGR (5Y)12.76%

Price vs S&P 500 (52W)24.51%

P/E Ratio (TTM)48.30x

Year-to-Date Return24.76%

5-Day Price Return-4.94%

EPS Normalized (Annual)$0.78

ROA (5Y Avg)2.86%

Net Profit Margin (Annual)3.40%

Month-to-Date Return-0.32%

EBITD / Share (Annual)$1.34

EPS Growth (3Y)10.88%

Operating Margin (Annual)5.02%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)23.71x

ROI (5Y Avg)14.34%

P/E Excl Extra (TTM)48.30x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$0.76

P/TBV (Quarterly)10.17x

P/B Ratio (Annual)9.26x

Inventory Turnover (TTM)27.55x

Pretax Margin (TTM)5.07%

Book Value / Share (Annual)$3.25

Price vs S&P 500 (13W)21.73%

Net Margin Growth (5Y)4.64%

Beta0.47x

P/FCF (Annual)29.45x

Revenue / Share (TTM)$21.63

ROE (TTM)27.53%

52-Week Low$19.17

Analyst Recommendations

Jan 2026

Feb 2026

Mar 2026

Apr 2026

4.30

4.36

Industry Peers — Drug Stores & Pharmacies(4)

Symbol	P/S Ratio (TTM)	ROE (TTM)	Operating Margin (TTM)	Revenue Growth TTM (YoY)	Price
GRDNGuardian Pharmacy Services, Inc.	1.64x	27.53%	5.02%	17.93%	$37.34
CVSCVS HEALTH CORPORATION	0.24x	2.34%	1.28%	7.85%	$76.58
PETSPetMed Express, Inc.	0.28x	-122.10%	-32.30%	-26.05%	$2.37
YI111, Inc. American Depositary Shares	0.03x	-178.33%	-0.07%	-7.36%	$6.60
RDGTRidgetech, Inc. Ordinary Shares	0.02x	41.78%	1.00%	-24.14%	$2.21

About

Guardian Pharmacy Services is a technology-enabled pharmacy services company serving long-term care facilities, assisted living facilities, and behavioral health facilities across the United States. The company provides customized medication management and clinical services designed to improve medication adherence, reduce care costs, and enhance patient outcomes. Its personalized approach differentiates it in serving lower-acuity care settings.